Syntara Limited has released a press release.
Trading Halt
Filed with ASX ·
On 6ix: 6ix.com/news/trading-halt-667
6ix hasn’t read this filing yet.
In the deck
Earlier from Syntara
- Response to ASX Price Query
- Pause in Trading
- Appendix 4E and Annual Report to shareholders
- Half Yearly Report and Accounts
- PXS Company Restructure Sale of Mannitol Business
Later from Syntara
- Presentation: Phase 2 study of SNT-5505 in myelofibrosis
- Interim data in Phase 2 study of SNT-5505 in myelofibrosis
- Equity Raising Presentation
- Placement
- Acceleration of skin scarring program
Follow Syntara into a list and get an email when it puts out news.
Follow Syntara